Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥6.1bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥6.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥1.5bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥1.1bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥1.5bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥1.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥1.5bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥1.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥947m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥642m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥950m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥643m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥6.7bnat 2023-12-31Cons.Assets
Total assets¥5.4bnat 2023-03-31Cons.Assets
Total assets¥4.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥1.5bnat 2023-12-31Cons.Liabilities
Total liabilities¥1.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥5.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥4.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥4.6bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥3.9bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥53.462023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.092023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥76.612022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥39.592022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.512022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥53.022023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥73.072022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥37.572022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio75.1%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio74.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥421m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥421m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥115m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥1.1bn
jpcrp040300-q3r_E38215-000Medical Platform Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥4.0bn
jpcrp040300-q3r_E38215-000Medical Platform Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥4.0bn
jpcrp040300-q3r_E38215-000Medical Platform Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.2bn
jpcrp040300-q3r_E38215-000Smart Clinic Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥1.7bn
jpcrp040300-q3r_E38215-000Smart Clinic Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.7bn
jpcrp040300-q3r_E38215-000Smart Clinic Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥313m
—segment totalrevenue2023-04-01 → 2023-12-31¥5.7bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥5.7bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥392m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥392m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥116m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥814m
jpcrp040300-q3r_E38215-000Medical Platform Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥2.8bn
jpcrp040300-q3r_E38215-000Medical Platform Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.8bn
jpcrp040300-q3r_E38215-000Medical Platform Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E38215-000Smart Clinic Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.3bn
jpcrp040300-q3r_E38215-000Smart Clinic Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.3bn
jpcrp040300-q3r_E38215-000Smart Clinic Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥292m
—segment totalrevenue2022-04-01 → 2022-12-31¥4.1bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥4.1bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥1.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥4.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥4.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥1.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 325
ItemContextValueUnit
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsOtherMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は100株であります。
Description issued shares voting rightsCurrentQuarterInstant_SharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Quarterly consolidated balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of income (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of comprehensive income (text)CurrentYTDDurationText · Plus
Notes changes in scope of consolidation or equity method (text)CurrentYTDDurationText · Plus
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)Prior1YTDDurationText · Plus
Notes when there is significant changes in amounts of equity (text)Prior1YTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes when there is significant changes in amounts of equity (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass